Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,846 | -1,783 | -1,004 | -3,411 | -2,746 |
| Depreciation Amortization | 278 | 120 | 54 | 235 | 198 |
| Accounts receivable | 0 | 1 | -1 | -76 | -172 |
| Other Working Capital | 1,154 | 930 | 452 | 1,552 | 1,358 |
| Other Operating Activity | 278 | 221 | 205 | 638 | 584 |
| Operating Cash Flow | $-1,136 | $-510 | $-295 | $-1,062 | $-779 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | -46 | -48 |
| Investing Cash Flow | $-5 | $N/A | $N/A | $-46 | $-48 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 857 | 257 | 257 | 468 | 120 |
| Common Stock Issued | N/A | 365 | 75 | 831 | 892 |
| Common Stock Repurchased | 365 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -43 | -43 | -43 | -242 | -242 |
| Financing Cash Flow | $1,180 | $580 | $290 | $1,056 | $770 |
| Beginning Cash Position | 6 | 6 | 6 | 57 | 57 |
| End Cash Position | 45 | 75 | 1 | 6 | 1 |
| Net Cash Flow | $39 | $69 | $-5 | $-51 | $-57 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,136 | -510 | -295 | -1,062 | -779 |
| Capital Expenditure | -5 | N/A | N/A | -46 | -48 |
| Free Cash Flow | -1,140 | -510 | -295 | -1,107 | -827 |